ARCHIVES

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988

Comprehensive Center NCAB Evaluations

June 2, 1978

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

Novel Agents Promise Relief From Hematologic Side Effects

July 27, 2001

In Brief; NCAB Goes Along With NCI Staff In Funding EORTC Statistical Center Grant Out Of Priority Sequence

November 20, 1981

SPORE Eligibility, Cost Issues Clarified In Addendum To RFA

October 25, 1991